AI Science Tracker

Dona Flor and her two husbands: Discovery of novel HDAC6/AKT2 inhibitors for myeloid cancer treatment.

Universidade de São Paulo; University of North Carolina at Chapel Hill; Martin Luther University Halle-Wittenberg · 28 Aug 2025 · medicine

Discovery

Dona Flor and her two husbands: Discovery of novel HDAC6/AKT2 inhibitors for myeloid cancer treatment.

Source check: Needs source check. Not independent scientific confirmation.

Finding / tested result: Screened hybrid inhibitors were synthesized and tested, revealing enzyme inhibition, cancer-cell activity and resistance reversal.

Technology: Random forest classifiers

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Random forest classifiers is the AI method documented in the editorial source review.
Limitation / still unknown
The date refers to the cited version. Earlier public versions and independent replication were not systematically verified.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.1016/j.compbiomed.2025.110990

Needs source check · editorial details

The source has not been fully checked or contains conflicting information. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review scope and date are not recorded; source checked does not establish full-text review.

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.